Tuesday, December 30, 2014 12:00:04 PM
Dilution goes to the holder of the shorted shares. Equity " shares " is like cash and used much the same. It is borrowed and loaned from shareholders and here how it works.
Equity is owed by the company to its equity holders as the company grows. This capital is put a side in a special ledger that can be lent out or shorted at any time by the company and belongs to the company as a whole with the whole divided up in parts " individual shareholders interest"
Until the dividing of the whole into its parts take place the equity can be loaned out to buyers of interest. This is done by one issuing a set price for the shares or a par value is set. The shares can be repurchased only above the set par value or price set in place much like an S1 filing.
So if the price is set at par .001 then that price has to be met.
Now lets say they don't pick up the shares then a dividend can be issued were for those shares and what they earned in that time period then reversed to match the original S1 offering through the bringing together all the interested parties in consolidations or a united union if you like.
Every one truly wins in the end if you stick with your guns. But should you sell below the S1 filing and not take in what is owed by the company represented by the outstanding share count then you are only cheating your self if you don't buy back in because its the company who buys back those shares and holds them for distribution at the lower price set in place.
All one has to do is watch for a symbol change take note of the offering price and don't buy for more then the offer but at the offer or below. Warrants are no different but often incorporate two trading symbols then moving to one. Sometimes two exchanges will be used or different classes of shares will be used to obtain the same result.
Recent PTIX News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:29:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 08:50:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 10:18:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:02:39 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/02/2023 08:29:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/13/2023 04:48:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 07:29:32 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM